The January/February issue of The Atlantic has a terrific interview with the biogeneticist Eric S. Lander about how genetic advances are transforming medical treatment. Lander says now is the time to invest in the riskiest, cleverest ideas to make transformative improvements in the lives of patients facing the most challenging diseases. His comments are very timely as Accelerate Brain Cancer Cure is poised to use genomics to help brain cancer patients.
Accelerate Brain Cancer Cure is a Washington DC-based venture philanthropy 501(c)(3) nonprofit organization that drives cutting-edge research and treatments for brain tumors. Copyright 2013 - All Rights Reserved.